Skip to main content
3 Wissenschaftler
© Universitätsklinikum Bonn / Alessandro Winkler

News categories: Publication

Immune cells remember their location

A new AI-based method reconstructs spatial information about where immune cells were originally located in an organ, even after these cells have been removed from the tissue and analyzed individually. To accomplish this, Researchers at the University Hospital Bonn (UKB) and the University of Bonn use the transcriptome, i.e., the entirety of all messenger RNA transcripts produced by genes within a cell at a given time. The work has now been published in the journal Advanced Science and introduces the new MERLIN algorithm.

How do immune cells change and contribute to diseases in organs? Single-cell RNA sequencing technology has revolutionized immunological research, by revealing which genes are active in individual immune cells. "However, when cells are isolated, information about which part of an organ the cells originated from is inevitably lost. In highly structured organs such as the kidney or brain, this spatial information is crucial for understanding health and disease," says Prof. Christian Kurts, Director of the Institute for Molecular Medicine and Experimental Immunology at the UKB. He is a member of the ImmunoSensation³ Cluster of Excellence and the Transdisciplinary Research Area (TRA) "Life & Health" at the University of Bonn.

MERLIN makes the memory of immune cells accessible

"We discovered that macrophages carry a molecular memory of their local environment," explains Junping Yin, first author of the study. "Even after isolation, their gene activity still reflects which area of the kidney or brain they originate from. MERLIN makes this information accessible again."

MERLIN was developed at the intersection of immunology, nephrology, and bioinformatics. The algorithm uses machine learning to recognize characteristic patterns in gene activity that are influenced by local tissue conditions such as oxygen deficiency or salt concentration.

"From a bioinformatics perspective, it was crucial that MERLIN be trained on multiple independent datasets," says Jian Li, senior author and bioinformatician. "This allows the system to learn real biological signals. It can then be applied to completely new or previously published datasets."

The researchers were able to show that MERLIN not only works in mouse models, but also correctly predicts the spatial origin of macrophages – large specialized white blood cells – in human kidney samples. In addition, the approach was transferred to the brain, where the positions of microglia, the brain's immune cells, were successfully reconstructed.

MERLIN provides new insights into kidney disease

The application to kidney disease is particularly relevant. By analyzing previously published data sets on inflammation, sepsis, ischemia-reperfusion injury occurring after transplantation, and diabetic nephropathy, MERLIN confirmed known disease mechanisms and provided new insights into region-specific immune responses and therapeutic effects. "This is a major advance for nephrology," emphasizes senior author Christian Kurts. "We see that immune responses and drug effects depend heavily on the specific region of the kidney, as we know from patient care."

The study was conducted at the UKB in the context of the ImmunoSensation³ Cluster of Excellence and TRA “Life & Health“ at the University of Bonn, which promote interdisciplinary research on the immune system. It also highlights the close international and national collaboration with researchers in Wuhan (China), at the University Medical Center Hamburg-Eppendorf, and at LMU Munich.

"MERLIN opens up a new dimension in single-cell research," summarizes Junping Yin. "We can re-evaluate existing data sets and gain a much more precise understanding of disease mechanisms."

Funding

In addition to funding from the ImmunoSensation³ Cluster of Excellence at the University of Bonn, the study was supported by the German Research Foundation (DFG) within the framework of TRR 237 Nucleic Acid Immunity and FOR 5427 Bacterial Renal Infections and Their Defense, and SFB 1192: Immune-Mediated Glomerular Diseases.

Publication

Junping Yin et al.: Predicting Macrophage Spatial Localization from Single-Cell Transcriptomes to Uncover Disease Mechanisms; Advanced Science; DOI: 10.1002/advs.202410924

Contact

Prof. Dr. Christian Kurts
Institute for Molecular Medicine and Experimental Immunology
University Hospital Bonn
ImmunoSensation3 and TRA & Life and Health Clusters of Excellence, University of Bonn
Email: ckurts@uni-bonn.de

Related news

News Icon

News categories: Publication

Malaria Causes Permanent Damage to Phagocytes in the Spleen

Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or “scavenger cells,” to a certain degree according to a study by the University of Bonn and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne. The researchers have demonstrated that malaria infection causes permanent damage to resident CD163 macrophages in the spleen, which are responsible for cleaning the blood, recycling iron and communicating with other cells involved in the body’s immune response.
View entry
Tracking glioblastoma cell spread in human brain tissue

News categories: Publication

Core2Edge: How tumor cells conquer the brain

Glioblastoma is an aggressive brain tumor that infiltrates deep into the surrounding brain tissue. Even after surgery, tumor cells remain in the brain and the tumor recurs. Bonn researchers have now developed Core2Edge, a model based entirely on human tissue that captures these hard-to-access infiltration zones at the tumor margin. The model enables investigation of the invasive front and direct assessment of new drug candidates in human tissue - without the need for animal testing. The study of the Brain Tumor Translational Research Group has now been published in Nature Protocols.
View entry
Mikrochip zur Wiederherstellung zentralen Sehvermögens bei fortgeschrittener Makuladegeneration.

News categories: Publication

Approval of a Novel Retinal Implant Technology

A novel retinal implant is offering people with geographic atrophy the opportunity to regain part of their central vision for the first time. Geographic atrophy is a severe late stage of age-related macular degeneration. An international research team led by Prof. Frank G. Holz of the UKB and the University of Bonn demonstrated in an international clinical trial that the majority of participants experienced significant improvements in visual acuity. The novel retinal implant technology has now received approval for routine clinical use in Europe, making it available beyond clinical trials.
View entry

Back to the news overview